| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9817 |
| Human Intestinal Absorption | HIA+ | 0.9960 |
| Caco-2 Permeability | Caco2+ | 0.8841 |
| P-glycoprotein Substrate | Non-substrate | 0.7352 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9549 |
| Non-inhibitor | 0.9522 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8726 |
| Distribution |
| Subcellular localization | Lysosome | 0.5047 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8047 |
| CYP450 2D6 Substrate | Non-substrate | 0.7902 |
| CYP450 3A4 Substrate | Non-substrate | 0.7183 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7640 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9240 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8657 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9423 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9474 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8105 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9415 |
| Non-inhibitor | 0.9360 |
| AMES Toxicity | Non AMES toxic | 0.9903 |
| Carcinogens | Carcinogens | 0.5154 |
| Fish Toxicity | High FHMT | 0.9525 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9947 |
| Honey Bee Toxicity | High HBT | 0.7348 |
| Biodegradation | Not ready biodegradable | 0.5309 |
| Acute Oral Toxicity | III | 0.7374 |
| Carcinogenicity (Three-class) | Warning | 0.5079 |